Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 209
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Q3’25 Psychedelic Drug Development Pipeline: Bullseye Charts
‘No Prejudice, No Hype’: Florence Butlen-Ducuing on Europe’s Psychedelic Renaissance
August 2025 Psychedelic Patent Update
Unpacking FDA’s MDMA Rejection Letter and the Road Ahead for Lykos
Pα+ Psychedelic Bulletin #208: Psychedelic CEOs’ FDA Wish-List; APA Division 56 President Talks Psychedelics; Compass’ PTSD Study Published; Cybin Ousts Drysdale
PTSF81 – Somatics, Reframing Trauma, and the 7 Lens Approach, with...
MindMed Joins Clinical Trials Transformation Initiative
The Therapeutic Effects of Psychedelics: 2A or Not 2A?-Part 2
PharmaTher Granted FDA Orphan Drug Designation For Ketamine To Treat Complex...
Mindset Pharma Expands Benchmarking Data for First Generation Psychedelics Through the...
Levitee Labs Appoints Dr. Mohammed Mosli as Chief People Officer of...
MYND Diagnostics Inc. Announces Participation in a Monash University (Australia) Proposal...
Numinus Upgrades Psychedelics Lab to Increase Research Service Capabilities
PT266 – Jerry B. Brown, Ph.D. – Psychedelics: Past, Present, and...
atai Life Sciences announces the launch of PsyProtix, to develop a...
1
...
208
209
210
...
296
Page 209 of 296